AMGN

Amgen
D

AMGN

Arincen67/100B

Amgen shares outstanding 1985–2026

Amgen had 540,911,490 shares outstanding on 12 November 2026. Amgen had 544.25M diluted shares on average over the last twelve months, up 0.5% on the twelve months before. In fiscal year 2025 the average was 542.00M.

Last updated 12 Nov 2026 · Next report 2 Feb 2027

Shares outstanding

Change on the year

Fiscal yearPeriod endingShares outstandingChange on the yearBasic shares
TTM30 Sept 2026544.25M+0.51%540.00M
FY202531 Dec 2025542.00M+0.18%538.00M
FY202431 Dec 2024541.00M+0.56%541.00M
FY202331 Dec 2023538.00M-0.55%535.00M
FY202231 Dec 2022541.00M-5.58%538.00M
FY202131 Dec 2021573.00M-2.88%570.00M
FY202031 Dec 2020590.00M-3.12%586.00M
FY201931 Dec 2019609.00M-8.42%605.00M
FY201831 Dec 2018665.00M-9.52%661.00M
FY201731 Dec 2017735.00M-2.52%731.00M
FY201631 Dec 2016754.00M-1.57%748.00M
FY201531 Dec 2015766.00M-0.52%758.00M
FY201431 Dec 2014770.00M+0.65%759.00M
FY201331 Dec 2013765.00M-2.80%753.00M
FY201231 Dec 2012787.00M-13.71%775.00M
FY201131 Dec 2011912.00M-5.49%905.00M
FY201031 Dec 2010965.00M-5.48%960.00M
FY200931 Dec 20091.02B-5.02%1.02B
FY200831 Dec 20081.08B-4.27%1.07B
FY200731 Dec 20071.12B-5.63%1.12B
FY200631 Dec 20061.19B-5.41%1.18B
FY200531 Dec 20051.26B-4.70%1.24B
FY200431 Dec 20041.32B-1.93%1.27B
FY200331 Dec 20031.35B+16.69%1.29B
FY200231 Dec 20021.15B+6.37%1.15B
FY200131 Dec 20011.08B-0.03%1.05B
FY200031 Dec 20001.08B+0.59%1.03B
FY199931 Dec 19991.08B+1.98%1.02B
FY199831 Dec 19981.06B-3.73%1.02B
FY199731 Dec 19971.10B-2.24%1.06B
FY199631 Dec 19961.12B-1.54%1.12B
FY199531 Dec 19951.14B+1.10%1.12B
FY199431 Dec 19941.13B+3.07%1.12B
FY199331 Dec 19931.10B-5.06%1.10B
FY199231 Dec 19921.15B+6.05%1.15B
FY199131 Dec 19911.09B+70.86%1.09B
FY199031 Dec 1990636.67M-22.36%636.67M
FY198831 Dec 1988820.00M-12.85%820.00M
FY198731 Dec 1987940.86M0.00%940.86M
FY198631 Dec 1986940.86M+61.97%940.86M
FY198531 Dec 1985580.90M—580.90M

Figures in USD. Shares and EPS are adjusted for stock splits. Quarterly growth is on the same quarter a year before; TTM is the last four quarters.

See also:Revenue,Net income,EPS,Operating income,Cash on hand,Total debt,Free cash flow,Stock buybacks,Income statement

Common questions about Amgen's shares

Source: Financial Modeling PrepVerified against SEC filings